DUBLIN–(BUSINESS WIRE)–The “Neurostimulation Devices Market Size, Share & Trends Analysis Report by Application (Pain Management, Parkinson’s Disease), by Product (Spinal Cord Stimulator, Gastric Electric Stimulator), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering.
The global neurostimulation devices market size is expected to reach USD 14.8 billion by 2030, registering a CAGR of 12.8%
Increasing prevalence of chronic diseases, such as migraine and epilepsy, due to unhealthy diets & lifestyle, and rising geriatric population across the globe are expected to be the major growth-driving factors for the market.
On the other hand, adverse effects and risks associated with neurostimulation devices and stringent regulations regarding product approval are expected to hamper the market growth to some extent. The increasing incidence of Road Traffic Accidents (RTAs) is another key factor supporting the market development.
In addition, manufacturers are investing in R&D activities to develop new products with advanced technology, such as MRI safety-incorporated devices by Medtronic Inc. and minimally invasive transdermal neuromodulation technology by Neurowave Medical Technologies.
Asia Pacific is projected to be the fastest-growing regional market from 2022 to 2030 on account of the rising healthcare expenditures and rapid economic growth in emerging countries, such as India and China. The presence of unmet medical needs and untapped markets are also boosting the market growth in the region.
Moreover, changing lifestyles and eating habits resulting in various lifestyle-related diseases will contribute to the regional market growth. The growing cases of RTAs and resultant nerve injuries, which require neurostimulation postoperatively, are also likely to boost the product demand.
Neurostimulation Devices Market Report Highlights
- North America is estimated to dominate the global market over the forecast period due to the rising product demand as an add-on therapy and high disposable income & patient awareness levels.
- The presence of sophisticated healthcare infrastructure and the growing prevalence of target diseases, such as epilepsy, Parkinson’s disease, and incontinence, are expected to drive the market growth further.
- The spinal cord stimulation product segment led the market in 2021 as these devices were the prime neurostimulation products to be commercialized.
- Pain management was the dominant application segment in 2021, in terms of revenue share, due to the high prevalence of chronic pain disorders and extensive product usage for pain management.
- New product and technological developments are the key business strategies followed by most of the market players.
Market Dynamics
Market Driver Analysis
- Growing geriatric population base
- Introduction of technological advancements
- Growing demand for neurostimulation devices as an add on therapy
- Increasing global prevalence of chronic diseases
- Growing prevalence of lifestyle-induced disorders
- External funding for executing research and development exercises
- Growing demand for minimally invasive surgeries
Market Restraint Analysis
- Adverse effects and risks associated with neurostimulation devices
- Presence of stringent device approval regulations
- Availability of external substitutes or alternative therapeutic procedures
Industry Challenges
- Presence of ambiguous regulatory framework
Company Profiles
- Medtronic
- St. Jude Medical
- Boston Scientific Corporation
- Cyberonics
- Nevro Corporation
- Neuronetics, Inc.
- Uroplasty
- Codman & Shurtleff’s
- Intrapace
For more information about this report visit https://www.researchandmarkets.com/r/5zq2b3
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
